Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-23

Clinical Trial Update: A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the safety of Fluticasone Propionate/Salmeterol 100/50 HFA versus Fluticasone Propionate 100 HFA in children with asthma; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Advair HFA (fluticasone propionate/salmeterol)
  • Fluticasone Propionate 100 HFA (Fluticasone Propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2010-09-23